Cargando…
Doxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro
BACKGROUND: Cancer therapy by systemic administration of anticancer drugs, besides the effectiveness shown on cancer cells, demonstrated the side effects and cytotoxicity on normal cells. The targeted drug-carrying nanoparticles may decrease the required drug concentration at the site and the distri...
Autores principales: | Phumyen, Achara, Jantasorn, Siriporn, Jumnainsong, Amonrat, Leelayuwat, Chanvit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259261/ https://www.ncbi.nlm.nih.gov/pubmed/25506223 http://dx.doi.org/10.2147/OTT.S69315 |
Ejemplares similares
-
Improved Binding Activity of Antibodies against Major Histocompatibility Complex Class I Chain-Related Gene A by Phage Display Technology for Cancer-Targeted Therapy
por: Phumyen, Achara, et al.
Publicado: (2012) -
Association of Major Histocompatibility Complex Class I Related Chain A/B Positive Microparticles with Acute Myocardial Infarction and Disease Severity
por: Haohan, Songpol, et al.
Publicado: (2020) -
Quantitative Multiplex Real-Time Reverse Transcriptase–Polymerase Chain Reaction with Fluorescent Probe Detection of Killer Immunoglobulin-Like Receptors, KIR2DL4/3DL3
por: Wongfieng, Wipaporn, et al.
Publicado: (2020) -
Regulation of KIR3DL3 Expression via miRNA
por: Nutalai, Rungtiwa, et al.
Publicado: (2019) -
5′-UTR and 3′-UTR Regulation of MICB Expression in Human Cancer Cells by Novel microRNAs
por: Wongfieng, Wipaporn, et al.
Publicado: (2017)